As the CEO and cofounder of Day Zero Diagnostics, I lead a team of passionate and talented scientists, engineers, and clinicians who are developing a breakthrough solution for infectious disease diagnostics. Our platform combines ultra-high enrichment sample prep, whole genome sequencing and machine learning to rapidly identify pathogens and profile antimicrobial resistance, enabling physicians to prescribe the most effective antibiotics in hours rather than days. DZD has won the MedTech Innovator Grand Prize, Harvard Presidential Innovation Award, the AACC Disruptive Technology Award, UCSF Health Award, and the Harvard Business School Alumni New Venture Competition.I have over 25 years of experience in the medical technology industry, spanning corporate strategy, product development, marketing, fundraising, and business development. I have successfully commercialized innovative medical devices with large scale potential in interventional cardiology, orthopedics and diagnostics. I have also advised and invested in several startups in the field, including Resolution Biosciences (acquired by Agilent). My mission is to leverage my expertise and network to bring disruptive solutions to the global healthcare market and improve patient outcomes.
Listed skills include Strategy, Start Ups, Business Strategy, Product Launch, and 37 others.